Breaking News Instant updates and real-time market news.

LPCN

Lipocine

$0.69

-0.103 (-13.03%)

09:07
11/14/19
11/14
09:07
11/14/19
09:07

Lipocine 10.45M share Secondary priced at 50c

Roth Capital acted as sole book running manager for the offering.

  • 14

    Nov

LPCN Lipocine
$0.69

-0.103 (-13.03%)

01/18/19
HCWC
01/18/19
NO CHANGE
Target $3
HCWC
Buy
Lipocine liver fat reduction data 'surprisingly strong,' says H.C. Wainwright
H.C. Wainwright analyst Oren Livnat says Lipocine yesterday reported "surprisingly strong" liver fat reduction interim data. The analyst reiterates a Buy rating on the shares with a $3 price target. The LPCN-1144 results could justify proceeding to a biopsy confirmed Phase 2a non-alcoholic steatohepatitis trial and inclusion of something for NASH in our valuation, Livnat tells investors in a research note.
03/13/19
HCWC
03/13/19
NO CHANGE
Target $5
HCWC
Buy
Lipocine price target raised to $5 from $3 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat raised his price target for Lipocine to $5 from $3 after the company announced final 16-week data from the small liver-fat imaging study of LPCN-1144. This builds on prior eight-week interim data, and bolsters evidence of liverfat reduction with oral testosterone, and the possibility it could be a genuine nonalcoholic steatohepatitis therapeutic candidate, Livnat tells investors in a research note. The analyst has "very cautiously" included some NASH value into his model and keeps a Buy rating on Lipocine.
11/11/19
LTCO
11/11/19
DOWNGRADE
LTCO
Neutral
Lipocine downgraded to Neutral from Buy at Ladenburg
Ladenburg analyst Matthew Kaplan downgraded Lipocine to Neutral from Buy.
11/11/19
HCWC
11/11/19
NO CHANGE
Target $2
HCWC
Buy
Lipocine price target lowered to $2 from $5 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat lowered his price target for Lipocine to $2 from $5 after the company received another Complete Response Letter for Tlando, its oral testosterone replacement therapy. The analyst says that if the FDA is going to hold to "these arbitrary" Cmax thresholds, he does not see any path to approval for Tlando. Livnat now assumes FDA "will not budge." As such, all focus will have to shift to the ongoing Phase 2 of LPCN-1144, an oral testosterone for nonalcoholic steatohepatitis, Livnat tells investors in a research note. This indication is an "extremely high-risk, high-reward play at this point," says the analyst, who sees a "positively skewed" risk/reward for Lipocine shares amid today's selloff. He keeps a Buy rating on the name.

TODAY'S FREE FLY STORIES

MORN

Morningstar

$154.47

-0.25 (-0.16%)

16:22
12/06/19
12/06
16:22
12/06/19
16:22
Hot Stocks
Morningstar raises quarterly dividend 7.1% to 30c from 28c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACEL

Alfacell Corporation

$11.11

0.1 (0.91%)

16:22
12/06/19
12/06
16:22
12/06/19
16:22
Hot Stocks
Crescent Park Management reports 6.4% passive stake in Accell »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$75.96

0.31 (0.41%)

16:21
12/06/19
12/06
16:21
12/06/19
16:21
Syndicate
Breaking Syndicate news story on Realty Income »

Realty Income files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/06/19
12/06
16:20
12/06/19
16:20
Options
Closing CBOE SPX and VIX Index summary for December 6th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

, BMY

Bristol-Myers

$59.94

0.435 (0.73%)

16:19
12/06/19
12/06
16:19
12/06/19
16:19
Hot Stocks
Bristol-Myers, Bluebird Bio: Phase 2 KarMMa study of ide-cel met endpoints »

Bristol-Myers Squibb…

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

BMY

Bristol-Myers

$59.94

0.435 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 11

    Dec

UBER

Uber

$27.87

-0.775 (-2.71%)

, ALXN

Alexion

$113.86

6.44 (6.00%)

16:18
12/06/19
12/06
16:18
12/06/19
16:18
On The Fly
Fly Intel: Wall Street's top stories for Friday »

For the first day in what…

UBER

Uber

$27.87

-0.775 (-2.71%)

ALXN

Alexion

$113.86

6.44 (6.00%)

MMM

3M

$171.43

7.07 (4.30%)

ICE

IntercontinentalExchange

$93.81

0.17 (0.18%)

TTD

Trade Desk

$247.63

7.36 (3.06%)

BIG

Big Lots

$25.22

6.05 (31.56%)

ULTA

Ulta Beauty

$262.19

26.1 (11.06%)

CIEN

Ciena

$35.01

-1.29 (-3.55%)

PD

PagerDuty

$21.81

-3.185 (-12.75%)

YEXT

Yext

$14.26

-2.355 (-14.17%)

ZM

Zoom Video

$62.76

-6.97 (-10.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 10

    Dec

  • 12

    Dec

  • 16

    Dec

  • 16

    Dec

  • 12

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
12/06/19
12/06
16:17
12/06/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLEX

Lilis Energy

$0.16

-0.0015 (-0.92%)

16:16
12/06/19
12/06
16:16
12/06/19
16:16
Hot Stocks
Lilis Energy discloses notice of NYSE listing deficiency »

Lilis Energ received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRE

Watford Holdings

$26.49

0.34 (1.30%)

16:16
12/06/19
12/06
16:16
12/06/19
16:16
Hot Stocks
Watford Holdings to acquire Axeria IARD, terms not disclosed »

Watford Holdings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
12/06/19
12/06
16:16
12/06/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMED

Ra Medical Systems

$1.22

-0.08 (-6.15%)

16:13
12/06/19
12/06
16:13
12/06/19
16:13
Hot Stocks
Ra Medical Systems receives noncompliance notice from NYSE »

Ra Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHX

L3Harris Technologies

$192.49

-0.98 (-0.51%)

16:12
12/06/19
12/06
16:12
12/06/19
16:12
Hot Stocks
L3Harris receives $50M follow-on order for HF radios from USMC »

L3Harris Technologies has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$24.16

0.715 (3.05%)

, NXPI

NXP Semiconductors

$118.43

1.28 (1.09%)

16:08
12/06/19
12/06
16:08
12/06/19
16:08
Earnings
Marvell cuts Q4 revenue view to $710M +/- 3% from $750M +/- 3% »

Q4 consensus $732.94M.…

MRVL

Marvell

$24.16

0.715 (3.05%)

NXPI

NXP Semiconductors

$118.43

1.28 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

DHR

Danaher

$148.23

1.16 (0.79%)

16:06
12/06/19
12/06
16:06
12/06/19
16:06
Options
Danaher rev/con volume near 100K is highest to date »

Danaher rev/con volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

CLDX

Celldex

$2.55

(0.00%)

16:05
12/06/19
12/06
16:05
12/06/19
16:05
Syndicate
Breaking Syndicate news story on Celldex »

Celldex files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNS

Cohen & Steers

$67.14

-0.17 (-0.25%)

, INB

Integrated BioPharma

$9.10

(0.00%)

16:03
12/06/19
12/06
16:03
12/06/19
16:03
Hot Stocks
Cohen & Steers announces approval of Global Income Builder reorganization »

Cohen & Steers Global…

CNS

Cohen & Steers

$67.14

-0.17 (-0.25%)

INB

Integrated BioPharma

$9.10

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ENSV

Enservco

$0.21

0.005 (2.40%)

16:03
12/06/19
12/06
16:03
12/06/19
16:03
Hot Stocks
Enservco discloses NYSE non-compliance letter »

Enservco announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Goldcorp

$39.84

-0.18 (-0.45%)

, ABX

Symbol changed to GOLD

$0.00

(0.00%)

15:45
12/06/19
12/06
15:45
12/06/19
15:45
Conference/Events
Odeon Capital metals/mining analyst to hold an analyst/industry conference call »

Analysts, along with Tony…

NEM

Newmont Goldcorp

$39.84

-0.18 (-0.45%)

ABX

Symbol changed to GOLD

$0.00

(0.00%)

KL

Kirkland Lake Gold

$40.53

-0.52 (-1.27%)

EVN

Eaton Vance Municipal Income Trust

$12.96

0.06 (0.47%)

NST

Nstar

$0.00

(0.00%)

AUY

Yamana Gold

$3.58

-0.195 (-5.17%)

DGC

Direct General Corp.

$0.00

(0.00%)

SAR

Saratoga Investment

$25.32

0.18 (0.72%)

EDV

Envision Development Corp.

$135.32

-1.28 (-0.94%)

CEY

Certegy

$22.88

(0.00%)

RSG

Republic Services

$88.92

0.675 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:45
12/06/19
12/06
15:45
12/06/19
15:45
General news
Treasury Market Summary »

Treasury Market Summary:…

XOM

Exxon Mobil

$69.57

1.16 (1.70%)

15:30
12/06/19
12/06
15:30
12/06/19
15:30
Hot Stocks
Exxon Mobil Treasurer sells 8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.46

0.055 (1.02%)

, TMUS

T-Mobile

$77.55

0.57 (0.74%)

15:26
12/06/19
12/06
15:26
12/06/19
15:26
Periodicals
Sprint, T-Mobile discussing last-minute settlement with AGs, FBN says »

Fox Business…

S

Sprint

$5.46

0.055 (1.02%)

TMUS

T-Mobile

$77.55

0.57 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

  • 16

    Dec

XOM

Exxon Mobil

$69.56

1.15 (1.68%)

15:24
12/06/19
12/06
15:24
12/06/19
15:24
Hot Stocks
Exxon Mobil Controller sells 9.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.22

0.035 (0.49%)

, COF

Capital One

$101.65

2.06 (2.07%)

15:22
12/06/19
12/06
15:22
12/06/19
15:22
Periodicals
Trump asks Supreme Court to block subpoenas for bank records, Politico says »

Politico's Andrew…

DB

Deutsche Bank

$7.22

0.035 (0.49%)

COF

Capital One

$101.65

2.06 (2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

HSBC

HSBC

$36.87

0.505 (1.39%)

15:17
12/06/19
12/06
15:17
12/06/19
15:17
Periodicals
HSBC exec Moses to announce departure next week, Bloomberg says »

HSBC chief risk officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/06/19
12/06
15:17
12/06/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.